News
Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release
Biotech gets back on track in November December 01, 2009 | Press Release
Biotech takes it on the chin in October November 02, 2009 | Press Release
See all NewsPrivate Equity
Burrill Private Equity Group’s active management creates value in investments through a structured and rigorous strategy which includes:
- Select (using our domain expertise and large proprietary deal flow) undervalued companies in which we can acquire significant influential stakes
- Acquire significant equity positions (often through PIPEs)
- Solidify investee’s financial position— removing financial instability
- Rationalize and/or accelerate pipeline development
- Create partnerships with major Pharma or other industry players
- Mentor management and take Board leadership position (augment Board)
- Institute appropriate financial controls
- Optimize opportunities for future equity financing, acquisitions, and divestitures.


